- AKRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $24.7 million.
- AKRX has traded 92,225 shares today.
- AKRX is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AKRX with the Ticky from Trade-Ideas. See the FREE profile for AKRX NOW at Trade-Ideas More details on AKRX: Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. AKRX has a PE ratio of 77.1. Currently there are 6 analysts that rate Akorn a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Akorn has been 986,500 shares per day over the past 30 days. Akorn has a market cap of $3.5 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.20 and a short float of 12.5% with 13.24 days to cover. Shares are up 38.1% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.